Etanercept

Phase 1Completed

0 watching 0 views this week💤 Quiet

Hype Score

Development Stage

✓

Pre-clinical

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Fanconi Anemia

Conditions

Fanconi Anemia

Trial Timeline

Oct 1, 2005 → Oct 1, 2010

NCT ID

NCT00965666

About Etanercept

Etanercept is a phase 1 stage product being developed by Amgen for Fanconi Anemia. The current trial status is completed. This product is registered under clinical trial identifier NCT00965666. Target conditions include Fanconi Anemia.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (20)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00111111	Phase 3	Completed	—	—	Psoriasis
NCT05135312	Approved	UNKNOWN	Aug 9, 2021	Aug 8, 2022	Psoriasis
NCT02749370	Approved	Completed	May 18, 2016	Dec 6, 2017	Plaque Psoriasis
NCT02274792	Approved	Completed	Jan 1, 2015	Nov 1, 2015	Plaque Psoriasis
NCT01971346	Approved	Completed	Mar 13, 2014	Nov 1, 2017	Psoriasis
NCT01543204	Approved	Terminated	Feb 1, 2012	May 29, 2015	Psoriasis
NCT01132235	Approved	UNKNOWN	Apr 1, 2010	Dec 1, 2010	Psoriasis
NCT01009879	Approved	Withdrawn	Nov 1, 2009	Feb 1, 2012	Rheumatoid Arthritis
NCT00833729	Approved	Completed	Feb 1, 2009	Feb 1, 2010	Plaque Psoriasis
NCT00640393	Approved	Completed	Apr 1, 2008	Mar 1, 2010	Psoriasis Vulgaris
NCT01053819	Approved	Completed	Sep 1, 2007	Apr 1, 2012	Psoriasis
NCT00477191	Pre-clinical	Terminated	May 1, 2007	Dec 1, 2013	Psoriasis
NCT00585650	Phase 1/2	Completed	May 1, 2007	May 1, 2008	Psoriasis
NCT00413452	Phase 3	Completed	Dec 1, 2006	Oct 1, 2007	Rheumatoid Arthritis
NCT00361634	Phase 1	Completed	Sep 1, 2006	Mar 1, 2010	Rheumatoid Arthritis
NCT00333034	Phase 3	Completed	Jun 1, 2006	May 1, 2007	Psoriasis
NCT00322439	Pre-clinical	Completed	May 1, 2006	Feb 8, 2013	Psoriasis
NCT00332332	Approved	Completed	Mar 1, 2006	Feb 1, 2010	Psoriasis
NCT00346294	Approved	Completed	Jan 1, 2006	Jul 1, 2006	Rheumatoid Arthritis
NCT00965666	Phase 1	Completed	Oct 1, 2005	Oct 1, 2010	Fanconi Anemia

Competing Products

4 competing products in Fanconi Anemia

See all competitors

Product	Company	Stage	Hype Score
RP-L102	Rocket Pharmaceuticals	Phase 2	44
RP-L102	Rocket Pharmaceuticals	Phase 1	25
RP-L102	Rocket Pharmaceuticals	Phase 2	44
Busulfan + Fludarabine + Cyclophosphamide + Anti-Thymocyte Globulin (Rabbit) + G-CSF	Brain Biotech	Phase 2	44

Other Products from Amgen